血小板在全身性硬化症中的多方面的作用:超越血液静止!
Veronica Batani1,2,3, Aslıhan Avanoglu Guler4, Jelena Colic5,6
1Department of Medical and Surgical Sciences for children and adults, University Hospital of Modena and Reggio Emilia School of Medicine, Modena.
Current opinion in hematology
|March 2, 2026
概括
血小板是系统性硬化症 (SSc) 中炎症和凝血的关键驱动因素,有助于器官损伤. 了解这些血小板驱动的途径可能会导致SSc.的新疗法.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 系统性硬化症 (SSc) 涉及血管损伤,免疫问题和纤维化.
- 在SSc中存在一种无法解释的血栓性负担,超出了传统的风险因素.
- 血小板越来越多地被认为是SSc病理生理学的核心参与者.
研究的目的:
- 审查SSc.中新兴的血小板驱动机制.
- 突出血小板的作用超出血静止.
- 讨论血小板作为传播器官损伤的血管内信使.
主要方法:
- 对实验和临床证据的文献综述.
- 在SSc.中分析血小板激活和功能.
- 检查血小板与免疫细胞的相互作用.
主要成果:
- 在SSc中的血小板由于内皮损伤和炎症而表现出持续的激活.
- 活性血小板通过与中性粒细胞的相互作用促进免疫血栓形成.
- 血小板介质传播炎症和益纤维细胞信号,导致内皮功能障碍和纤维化.
结论:
- 血小板在SSc中协调免疫血栓形成和血栓炎症.
- 血小板信号网络为风险分层和治疗提供了目标.
- 目前对SSc中疾病修饰性抗血小板干预的证据有限.
相关概念视频
Formation of the Platelet Plug
10.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.1K
Structure and Function of Platelets
4.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Introduction to Hemostasis
15.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
15.4K
Clot Retraction and Fibrinolysis
9.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.7K


